Boehringer Ingelheim new data from two trials showing Spiolto® Respimat® provides significant quality of life improvements in patients with moderate to severe COPD

Published 29, September 2015 at 172 × 132 in Boehringer Ingelheim: new data from two trials showing Spiolto® Respimat® provides significant quality of life improvements in patients with moderate to severe COPD

Boehringer Ingelheim: new data from two trials showing Spiolto® Respimat® provides significant quality of life improvements in patients with moderate to severe COPD

Boehringer Ingelheim: new data from two trials showing Spiolto® Respimat® provides significant quality of life improvements in patients with moderate to severe COPD

Bookmark the permalink.

Comments are closed.